CID 169501900

Sildenafil metabolite m8

Structural Information

Molecular Formula
C19H26N6O5S
SMILES
CCOC1=C(C=C(C=C1)S(=O)(=O)NCCN)C2=NC3=C(C(=O)N2)N(N=C3CC(C)O)C
InChI
InChI=1S/C19H26N6O5S/c1-4-30-15-6-5-12(31(28,29)21-8-7-20)10-13(15)18-22-16-14(9-11(2)26)24-25(3)17(16)19(27)23-18/h5-6,10-11,21,26H,4,7-9,20H2,1-3H3,(H,22,23,27)
InChIKey
HRBHANGXLRNHSE-UHFFFAOYSA-N
Compound name
N-(2-aminoethyl)-4-ethoxy-3-[3-(2-hydroxypropyl)-1-methyl-7-oxo-6H-pyrazolo[4,5-d]pyrimidin-5-yl]benzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

450.16855 Da
Monoisotopic Mass

-0.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 451.175826 205.8
[M+Na]+ 473.157768 214.4
[M-H]- 449.161274 206.9
[M+NH4]+ 468.202373 211.0
[M+K]+ 489.131708 208.2
[M+H-H2O]+ 433.165810 197.4
[M+HCOO]- 495.166751 217.2
[M+CH3COO]- 509.182401 231.5
[M+Na-2H]- 471.143216 206.8
[M]+ 450.16800142 211.9
[M]- 450.16909858 211.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.